Literature DB >> 24823469

[Electrical storm in ICD patients: prevention and treatment].

Markus Zarse1, Harilaos Bogossian, Bernd Lemke.   

Abstract

Medical progress and demographic changes cause a continuous increase in patients with implantable cardioverter-defibrillators (ICD). Up to one third of patients with ICDs for secondary prevention and half of the patients with previous electrical storm (ES) will suffer from (further) ESs. When multiple ICD shocks are reported by patients (ICD storm), appropriate, inappropriate and phantom shocks have to be distinguished. Reported shocks without clinical correlates (phantom) often affect patients suffering from posttraumatic stress syndrome after an ICD storm. Approximately one third of all ICD shocks are inappropriate, most often due to supraventricular tachycardia with fast atrioventricular (AV) nodal conduction or lead failure. Within 10 years after implantation lead failure can be detected in up to 20 % of cases and approximately one third of these failures are only seen after inappropriate ICD shocks. Furthermore, inappropriate shocks are due to oversensing of far field atrial electrograms, T-waves, diaphragmatic potentials and electrical noise.Appropriate ICD shocks can rarely also be stimulated by the proarrhythmogenicity of lead implantation or ICD programming. Modifications of the waiting period to therapy, time to detection, detection window, antitachycardia pacing (ATP) stimulation and supraventricular discrimination algorithms may minimize ICD shocks. Some stimulation algorithms may improve the hemodynamic stability during ES. In addition to ventricular ablation, blockade of the sympathetic autonomic nervous system and antiarrhythmic treatment are the main pillars of ES treatment. The best ES prevention, however, is optimized heart failure treatment, especially when a cardiac resynchronization with defibrillator (CRT-D) system is implanted.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24823469     DOI: 10.1007/s00399-014-0307-9

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  29 in total

1.  Inhibition of bradycardia pacing and detection of ventricular fibrillation due to far-field atrial sensing in a triple chamber implantable cardioverter defibrillator.

Authors:  Dirk Vollmann; Lars Lüthje; Georg Görtler; Christina Unterberg
Journal:  Pacing Clin Electrophysiol       Date:  2002-10       Impact factor: 1.976

2.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

3.  Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group.

Authors:  A Pacifico; S H Hohnloser; J H Williams; B Tao; S Saksena; P D Henry; E N Prystowsky
Journal:  N Engl J Med       Date:  1999-06-17       Impact factor: 91.245

4.  Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.

Authors:  Stuart J Connolly; Paul Dorian; Robin S Roberts; Michael Gent; Steven Bailin; Eric S Fain; Kevin Thorpe; Jean Champagne; Mario Talajic; Benoit Coutu; Gerian C Gronefeld; Stefan H Hohnloser
Journal:  JAMA       Date:  2006-01-11       Impact factor: 56.272

5.  Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.

Authors:  T Jared Bunch; Srijoy Mahapatra; David Murdock; Jamie Molden; J Peter Weiss; Heidi T May; Tami L Bair; Katy M Mader; Brian G Crandall; John D Day; Jeffrey S Osborn; Joseph B Muhlestein; Donald L Lappe; Jeffrey L Anderson
Journal:  Pacing Clin Electrophysiol       Date:  2011-09-03       Impact factor: 1.976

6.  Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.

Authors:  James P Daubert; Wojciech Zareba; David S Cannom; Scott McNitt; Spencer Z Rosero; Paul Wang; Claudio Schuger; Jonathan S Steinberg; Steven L Higgins; David J Wilber; Helmut Klein; Mark L Andrews; W Jackson Hall; Arthur J Moss
Journal:  J Am Coll Cardiol       Date:  2008-04-08       Impact factor: 24.094

Review 7.  Anger and ventricular arrhythmias.

Authors:  Rachel Lampert
Journal:  Curr Opin Cardiol       Date:  2010-01       Impact factor: 2.161

8.  Comparison of frequency of aggravation of ventricular tachyarrhythmias after implantation of automatic defibrillators using epicardial versus nonthoracotomy lead systems.

Authors:  D Böcker; M Block; F Isbruch; D Wietholt; D Hammel; H H Scheld; M Borggrefe; G Breithardt
Journal:  Am J Cardiol       Date:  1993-05-01       Impact factor: 2.778

9.  Dyssynchrony and the risk of ventricular arrhythmias.

Authors:  Valentina Kutyifa; Anne-Catherine Pouleur; Dorit Knappe; Amin Al-Ahmad; Michal Gibinski; Paul J Wang; Scott McNitt; Bela Merkely; Ilan Goldenberg; Scott D Solomon; Arthur J Moss; Wojciech Zareba
Journal:  JACC Cardiovasc Imaging       Date:  2013-04

10.  Prospective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional anti-tachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients-Atp DeliVery for pAiNless ICD thErapy (ADVANCE-D) Trial results.

Authors:  Massimo Santini; Maurizio Lunati; Pascal Defaye; Johann Mermi; Alessandro Proclemer; Silvia del Castillo-Arroys; Giulio Molon; Elisabetta Santi; Tiziana De Santo; Xavier Navarro; Axel Kloppe
Journal:  J Interv Card Electrophysiol       Date:  2010-01-20       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.